Graham Capital Management’s Applied Therapeutics APLT Stock Holding History

Graham Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-572,759	Closed	-$57.3K	–	1147
2025 Q4	$57.3K	Buy	+572,759	New	+$364K	﹤0.01%	1171

Graham Capital Management's APLT Position: Q1 2026 in Review

Graham Capital Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 572,759 shares — an estimated $57.3K sold.

Graham Capital Management first reported a position in APLT in Q4 2025 and held it in 1 quarter. The position peaked at $57.3K in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Graham Capital Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 572,759 Applied Therapeutics shares in Q1 2026, an estimated $57.3K.
Graham Capital Management first reported a position in Applied Therapeutics in Q4 2025 and held it in 1 quarter.
Graham Capital Management's Applied Therapeutics position peaked at $57.3K in Q4 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.